These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 23461356

  • 1. Peroxisome proliferator-activated receptor-γ activation inhibits hepatocellular carcinoma cell invasion by upregulating plasminogen activator inhibitor-1.
    Pang X, Wei Y, Zhang Y, Zhang M, Lu Y, Shen P.
    Cancer Sci; 2013 Jun; 104(6):672-80. PubMed ID: 23461356
    [Abstract] [Full Text] [Related]

  • 2. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
    Kim KR, Choi HN, Lee HJ, Baek HA, Park HS, Jang KY, Chung MJ, Moon WS.
    Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
    [Abstract] [Full Text] [Related]

  • 3. Peroxisome Proliferator-Activated Receptor γ Expression Is Inversely Associated with Macroscopic Vascular Invasion in Human Hepatocellular Carcinoma.
    Hsu HT, Sung MT, Lee CC, Kuo YJ, Chi CW, Lee HC, Hsia CY.
    Int J Mol Sci; 2016 Jul 29; 17(8):. PubMed ID: 27483249
    [Abstract] [Full Text] [Related]

  • 4. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
    Cao LQ, Shao ZL, Liang HH, Zhang DW, Yang XW, Jiang XF, Xue P.
    Cancer Lett; 2015 Apr 01; 359(1):127-35. PubMed ID: 25592041
    [Abstract] [Full Text] [Related]

  • 5. Activation of peroxisome proliferator-activated receptor-gamma inhibits tumor growth by negatively regulating nuclear factor-κB activation in patients with hepatocellular carcinoma.
    Nojima H, Kuboki S, Shinoda K, Shimizu H, Ohtsuka M, Kato A, Yoshitomi H, Furukawa K, Takayashiki T, Miyazaki M.
    J Hepatobiliary Pancreat Sci; 2016 Sep 01; 23(9):574-84. PubMed ID: 27451128
    [Abstract] [Full Text] [Related]

  • 6. [The expression and clinopathological significance of miR-130b in human hepatocellular carcinoma].
    Xu Q, Cai W, Zhang M, Liu Q, Liu X.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2016 Mar 01; 32(3):387-92. PubMed ID: 26927562
    [Abstract] [Full Text] [Related]

  • 7. The insulin receptor: a new anticancer target for peroxisome proliferator-activated receptor-gamma (PPARgamma) and thiazolidinedione-PPARgamma agonists.
    Costa V, Foti D, Paonessa F, Chiefari E, Palaia L, Brunetti G, Gulletta E, Fusco A, Brunetti A.
    Endocr Relat Cancer; 2008 Mar 01; 15(1):325-35. PubMed ID: 18310298
    [Abstract] [Full Text] [Related]

  • 8. Hispidulin inhibits hepatocellular carcinoma growth and metastasis through AMPK and ERK signaling mediated activation of PPARγ.
    Han M, Gao H, Ju P, Gao MQ, Yuan YP, Chen XH, Liu KL, Han YT, Han ZW.
    Biomed Pharmacother; 2018 Jul 01; 103():272-283. PubMed ID: 29656183
    [Abstract] [Full Text] [Related]

  • 9. Overexpression of Jab1 in hepatocellular carcinoma and its inhibition by peroxisome proliferator-activated receptor{gamma} ligands in vitro and in vivo.
    Hsu MC, Huang CC, Chang HC, Hu TH, Hung WC.
    Clin Cancer Res; 2008 Jul 01; 14(13):4045-52. PubMed ID: 18593980
    [Abstract] [Full Text] [Related]

  • 10. CITED2 is a novel direct effector of peroxisome proliferator-activated receptor γ in suppressing hepatocellular carcinoma cell growth.
    Cheung KF, Zhao J, Hao Y, Li X, Lowe AW, Cheng AS, Sung JJ, Yu J.
    Cancer; 2013 Mar 15; 119(6):1217-26. PubMed ID: 23212831
    [Abstract] [Full Text] [Related]

  • 11. PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice.
    Shen B, Chu ES, Zhao G, Man K, Wu CW, Cheng JT, Li G, Nie Y, Lo CM, Teoh N, Farrell GC, Sung JJ, Yu J.
    Br J Cancer; 2012 Apr 24; 106(9):1486-94. PubMed ID: 22472882
    [Abstract] [Full Text] [Related]

  • 12. MicroRNA-130b promotes cell aggressiveness by inhibiting peroxisome proliferator-activated receptor gamma in human hepatocellular carcinoma.
    Tu K, Zheng X, Dou C, Li C, Yang W, Yao Y, Liu Q.
    Int J Mol Sci; 2014 Nov 07; 15(11):20486-99. PubMed ID: 25387077
    [Abstract] [Full Text] [Related]

  • 13. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q, Tang ZY, Xue Q, Shi DR, Song HY, Tang HB.
    J Cancer Res Clin Oncol; 2000 Nov 07; 126(11):641-6. PubMed ID: 11079728
    [Abstract] [Full Text] [Related]

  • 14. Peroxisome proliferator-activated receptor gamma inhibition prevents adhesion to the extracellular matrix and induces anoikis in hepatocellular carcinoma cells.
    Schaefer KL, Wada K, Takahashi H, Matsuhashi N, Ohnishi S, Wolfe MM, Turner JR, Nakajima A, Borkan SC, Saubermann LJ.
    Cancer Res; 2005 Mar 15; 65(6):2251-9. PubMed ID: 15781638
    [Abstract] [Full Text] [Related]

  • 15. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
    Yu J, Shen B, Chu ES, Teoh N, Cheung KF, Wu CW, Wang S, Lam CN, Feng H, Zhao J, Cheng AS, To KF, Chan HL, Sung JJ.
    Hepatology; 2010 Jun 15; 51(6):2008-19. PubMed ID: 20512989
    [Abstract] [Full Text] [Related]

  • 16. 15-PGDH inhibits hepatocellular carcinoma growth through 15-keto-PGE2/PPARγ-mediated activation of p21WAF1/Cip1.
    Lu D, Han C, Wu T.
    Oncogene; 2014 Feb 27; 33(9):1101-12. PubMed ID: 23542179
    [Abstract] [Full Text] [Related]

  • 17. VSP‑17 suppresses the migration and invasion of triple‑negative breast cancer cells through inhibition of the EMT process via the PPARγ/AMPK signaling pathway.
    Xu X, Liu M, Yang Y, Wei C, Zhang X, Song H, Wang Y, Duan X.
    Oncol Rep; 2021 Mar 27; 45(3):975-986. PubMed ID: 33650675
    [Abstract] [Full Text] [Related]

  • 18. PPARγ Coactivator-1α Suppresses Metastasis of Hepatocellular Carcinoma by Inhibiting Warburg Effect by PPARγ-Dependent WNT/β-Catenin/Pyruvate Dehydrogenase Kinase Isozyme 1 Axis.
    Zuo Q, He J, Zhang S, Wang H, Jin G, Jin H, Cheng Z, Tao X, Yu C, Li B, Yang C, Wang S, Lv Y, Zhao F, Yao M, Cong W, Wang C, Qin W.
    Hepatology; 2021 Feb 27; 73(2):644-660. PubMed ID: 32298475
    [Abstract] [Full Text] [Related]

  • 19. Functional role of peroxisome-proliferator-activated receptor γ in hepatocellular carcinoma.
    Wu CW, Farrell GC, Yu J.
    J Gastroenterol Hepatol; 2012 Nov 27; 27(11):1665-9. PubMed ID: 22742931
    [Abstract] [Full Text] [Related]

  • 20. Activation of peroxisome proliferator-activated receptor-gamma decreases pancreatic cancer cell invasion through modulation of the plasminogen activator system.
    Sawai H, Liu J, Reber HA, Hines OJ, Eibl G.
    Mol Cancer Res; 2006 Mar 27; 4(3):159-67. PubMed ID: 16547153
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.